Established and evolving indications for cardiac resynchronisation

H J Nesser1, O-A Breithardt, B K Khandheria

  • 1Public Hospital Elisabethinen, Department of Cardiology, Academic Teaching Hospital of the University of Vienna and Innsbruck, A-4020 Linz, Fadingerstrasse 1, Austria. hans-joachim.nesser@elisabethinen.or.at

Insights

Cardiac resynchronisation therapy (CRT) benefits heart failure patients who do not respond to medical treatment. Echocardiography with Doppler imaging may improve patient selection for CRT by identifying cardiac dyssynchrony.

Area of Science:

  • Cardiology and Cardiovascular Imaging

Background:

  • Cardiac resynchronisation therapy (CRT) is beneficial for heart failure patients unresponsive to optimal medical treatment.
  • Patient selection is crucial for CRT efficacy, with cardiac dyssynchrony being a key indicator.

Purpose of the Study:

  • To evaluate the role of echocardiography, particularly with Doppler myocardial imaging, in selecting patients for CRT.
  • To explore if echocardiographic findings can supplement or replace current electrocardiographic criteria for CRT patient selection.

Main Methods:

  • Review of randomised trials involving large patient cohorts.
  • Analysis of echocardiography and Doppler myocardial imaging in identifying cardiac dyssynchrony.
  • Comparison of echocardiographic criteria with existing electrocardiographic criteria for patient selection.

Main Results:

  • Large-scale trials confirm CRT benefits in selected heart failure patients.
  • Echocardiography, especially with Doppler myocardial imaging, is effective in defining the cardiac dyssynchrony necessary for optimal patient selection.
  • Echocardiographic findings show potential to complement electrocardiographic criteria.

Conclusions:

  • Echocardiography with Doppler myocardial imaging is a valuable tool for identifying cardiac dyssynchrony in heart failure patients.
  • This imaging modality may eventually supersede electrocardiographic criteria for selecting patients who will benefit from cardiac resynchronisation therapy.

Related Concept Videos

Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase of...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...